Stephen Mahoney - President and CEO, Director at Viridian Therapeutics, Inc.\DE

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
VRDN on Nasdaq
Industry
Services-Medical Laboratories
All Insider Reports
All Insider Reports

Stephen Mahoney - trading volume in the past year for Viridian Therapeutics, Inc.\DE

Holdings reported by Stephen Mahoney for Viridian Therapeutics, Inc.\DE

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 21.4K $499K $23.33 Sep 27, 2024 Direct
Stock Option (Right to Buy) 1.26M Oct 30, 2023 Direct Common Stock

Transactions reported by Stephen Mahoney for Viridian Therapeutics, Inc.\DE

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.